{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T16:20:20Z","timestamp":1775146820845,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy &amp; Behavior"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.yebeh.2019.106584","type":"journal-article","created":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T14:02:40Z","timestamp":1572444160000},"page":"106584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"PA","title":["Prevalence of valproate prescriptions in women of childbearing age in certain regions of Russia"],"prefix":"10.1016","volume":"101","author":[{"given":"Karel","family":"Kostev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Galina","family":"Osina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flora","family":"Rider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alla","family":"Guekht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.yebeh.2019.106584_bb0005","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s11096-018-0641-9","article-title":"Comparative efficacy of antiepileptic drugs for patients with generalized epileptic seizures: systematic review and network meta-analyses","volume":"40","author":"Campos","year":"2018","journal-title":"Int J Clin Pharmacol"},{"key":"10.1016\/j.yebeh.2019.106584_bb0010","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/epi.13415","article-title":"Antiepileptic drug combinations not involving valproate and the risk of fetal malformations","volume":"57","author":"Vajda","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.106584_bb0015","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa0803531","article-title":"Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs","volume":"360","author":"Meador","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2019.106584_bb0020","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1474-4422(12)70323-X","article-title":"Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study","volume":"12","author":"Meador","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2019.106584_bb0025","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/adc.2009.176990","article-title":"Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine","volume":"96","author":"Cummings","year":"2011","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.yebeh.2019.106584_bb0030","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.yebeh.2008.01.010","article-title":"Motor and mental development of infants exposed to antiepileptic drugs in utero","volume":"13","author":"Thomas","year":"2008","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.106584_bb0035","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1111\/j.1528-1167.2010.02668.x","article-title":"Early cognitive development in children born to women with epilepsy: a prospective report","volume":"51","author":"Bromley","year":"2010","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.yebeh.2019.106584_bb0040","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/adc.2008.144386","article-title":"Changing trends in antiepileptic drug prescribing in girls of child-bearing potential","volume":"94","author":"Ackers","year":"2009","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.yebeh.2019.106584_bb0045","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.seizure.2016.01.019","article-title":"Prescribing trends for sodiumvalproate in Ireland","volume":"36","author":"Murphy","year":"2016","journal-title":"Seizure"},{"issue":"6","key":"10.1016\/j.yebeh.2019.106584_bb0050","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/ene.13610","article-title":"Declining trend in valproate use in Finland among females of childbearing age in 2012\u20132016 \u2014 a nationwide registry based outpatient study","volume":"25","author":"Virta","year":"2018","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.yebeh.2019.106584_bb0055","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.yebeh.2018.12.002","article-title":"Trends in valproate use in patients in Germany between 2009 and 2017","volume":"92","author":"Jacob","year":"2019","journal-title":"Epilepsy Behav"},{"issue":"8","key":"10.1016\/j.yebeh.2019.106584_bb0060","article-title":"Use of antiepileptic drugs in women of fertile age","volume":"66","author":"Daugaard","year":"2019","journal-title":"Dan Med J"},{"key":"10.1016\/j.yebeh.2019.106584_bb0065","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.seizure.2019.07.001","article-title":"Valproate utilisation trends among girls and women from 2013 to 2018","volume":"70","author":"Puteikis","year":"2019","journal-title":"Seizure."},{"issue":"3","key":"10.1016\/j.yebeh.2019.106584_bb0070","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/epi4.12228","article-title":"Valproic acid utilization among girls and women in Stockholm: impact of regulatory restrictions","volume":"3","author":"Karlsson Lind","year":"2018","journal-title":"Epilepsia Open"},{"issue":"2","key":"10.1016\/j.yebeh.2019.106584_bb0075","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1600-0404.2009.01260.x","article-title":"Changing patterns of antiepileptic drug use in pregnant Australian women","volume":"121","author":"Vajda","year":"2010","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"10.1016\/j.yebeh.2019.106584_bb0080","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jnnp.2005.074203","article-title":"Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register","volume":"77","author":"Morrow","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.yebeh.2019.106584_bb0085","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1212\/WNL.0000000000001772","article-title":"Dose-dependent teratogenicity of valproate in mono- and polytherapy: an observational study","volume":"85","author":"Tomson","year":"2015","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.yebeh.2019.106584_bb0090","doi-asserted-by":"crossref","first-page":"129","DOI":"10.17116\/jnevro2017117111129-134","article-title":"Depakine: 25 years in Russia","volume":"117","author":"Karlov","year":"2017","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"issue":"special issue 1","key":"10.1016\/j.yebeh.2019.106584_bb0095","doi-asserted-by":"crossref","first-page":"4","DOI":"10.14412\/2074-2711-2015-1S-4-9","article-title":"Use of valproates in women of childbearing age and pregnant women with epilepsy","author":"Vlasov","year":"2015","journal-title":"Neurol Neuropsychiatr Psychosom"},{"issue":"5","key":"10.1016\/j.yebeh.2019.106584_bb0100","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1528-1167.2009.02129.x","volume":"50","author":"Harden","year":"2009","journal-title":"Epilepsia."},{"key":"10.1016\/j.yebeh.2019.106584_bb0110","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2019.0447","article-title":"Antiepileptic drug treatment patterns in women of childbearing age with epilepsy","author":"Kim","year":"2019","journal-title":"JAMA Neurol"},{"issue":"Pt A","key":"10.1016\/j.yebeh.2019.106584_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yebeh.2019.06.031","article-title":"Why do some women with epilepsy use valproic acid despite current guidelines? A single-center cohort study","volume":"98","author":"Bosak","year":"2019","journal-title":"Epilepsy Behav"},{"issue":"5","key":"10.1016\/j.yebeh.2019.106584_bb0120","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1212\/WNL.0000000000002791","article-title":"Nonadherence to antiepileptic drugs in Germany: a retrospective, population-based study","volume":"87","author":"Gollwitzer","year":"2016","journal-title":"Neurology."},{"key":"10.1016\/j.yebeh.2019.106584_bb0125","series-title":"Epilepsy and female reproductive health","first-page":"248","author":"Zhidkova","year":"2012"},{"key":"10.1016\/j.yebeh.2019.106584_bb0130","series-title":"Epilepsy in children and adults, women and men","first-page":"543","article-title":"Epilepsy and pregnancy","volume":"vol. 32","author":"Karlov","year":"2010"},{"issue":"2\u20133","key":"10.1016\/j.yebeh.2019.106584_bb0135","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.eplepsyres.2010.09.011","article-title":"The epidemiology of epilepsy in the Russian Federation","volume":"92","author":"Guekht","year":"2010","journal-title":"Epilepsy Res"}],"container-title":["Epilepsy &amp; Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505019310133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505019310133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:29:31Z","timestamp":1761503371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505019310133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":26,"alternative-id":["S1525505019310133"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2019.106584","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of valproate prescriptions in women of childbearing age in certain regions of Russia","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2019.106584","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106584"}}